Search

everythinglearnresearchcommunity

for

Search:↓

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Avacopan may cause unexpected side effects, so early monitoring is important.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Some flavonoids may help with hair growth by affecting blood vessel function in hair follicles.

Certain medications can cause serious side effects, so it's important to report them.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

The combined treatment effectively treats androgenetic alopecia and improves quality of life.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Talquetamab may cause hair loss and skin issues.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Fractional Er:YAG laser with PRP is more effective and has fewer side effects than microneedling with PRP for vitiligo.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.